Eric McFarland to Serve as NewHydrogen Chief Technology

Veteran energy expert to lead technical development and commercialization of the Company’s green hydrogen technology

SANTA CLARITA, Calif., April 29, 2025 (GLOBE NEWSWIRE) — NewHydrogen, Inc. (OTCQB:NEWH), the developer of ThermoLoop^™, a breakthrough technology that uses water and heat rather than electricity to produce the world’s cheapest green hydrogen, today announced the appointment of Dr. Eric McFarland as Chief Technology Officer.

As CTO, Dr. McFarland will evolve the company’s technology strategy and help accelerate ThermoLoop’s advancement from the laboratory and pilot scale to the commercial marketplace. McFarland will also continue to work with the scientific team at the University of California, Santa Barbara (UCSB), led by Dr. Phil Christopher.

“Dr. McFarland brings deep technical insight and decades of experience in energy systems and reaction engineering,” said Steve Hill, CEO of NewHydrogen. “He’s played a key role in shaping our technology development through our UCSB partnership. As CTO, he will continue to focus on ThermoLoop technology development and proof of concept. Dr. McFarland is also uniquely qualified to guide us through the commercial demonstration process.”

“I’m excited to expand my role with NewHydrogen at this pivotal time,” said Dr. McFarland. “We’ve already demonstrated the scientific viability of this technology, and I look forward to working closely with the team to optimize performance, reduce costs, and move toward commercial deployment.”

Eric McFarland studied Nuclear Engineering and received B.S. and M.S. degrees from U.C. Berkeley, and his Ph.D. from the Massachusetts Institute of Technology. He joined the Nuclear Engineering faculty at MIT where his research moved from nuclear reaction fundamentals to use of nuclear phenomena for non-destructive materials and chemical analysis. In 1991 McFarland moved to the University of California, Santa Barbara, where he is a Professor of Chemical Engineering. McFarland’s academic research in energy conversion technology and reaction engineering has been both fundamental and applied. He has published over 200 scientific papers and is the inventor on over 30 patents.

McFarland has always worked closely with industry and has been a founder or co-founder of a number of chemical technology companies and has served in several executive and Board positions. Together with other University faculty, he was one of the founding directors of Symyx Technologies a chemical technology start-up that went on to have a successful public offering. McFarland served as CEO and President of Gas Reaction Technologies Inc. (GRT) that had major R&D programs with several global oil and gas companies. McFarland was awarded the Dow Chemical Chair of Chemical Engineering at the University of Queensland, Australia and spent two-years as the founding Director of the Dow Centre for Sustainable Engineering Innovation. He was a founder and served as Chief Technology Officer of CZero a company developing technology to use fossil resources for hydrogen production without carbon dioxide emissions. McFarland also studied medicine and earned an M.D. from Harvard Medical School and did post-graduate training in general surgery. He practiced part-time in Emergency Medicine and worked as a volunteer physician for several relief agencies.

NewHydrogen recently filed a joint U.S. patent application with UCSB for its novel hydrogen production process, marking a significant milestone in the development of its ThermoLoop technology.

To learn more about ThermoLoop^™ and NewHydrogen’s mission to deliver the world’s cheapest green hydrogen, please visit https://newhydrogen.com.

About NewHydrogen, Inc.

NewHydrogen is developing ThermoLoop^™ – a breakthrough technology that uses water and heat rather than electricity to produce the world’s lowest cost green hydrogen. Hydrogen is the cleanest and most abundant element in the universe, and we can’t live without it. Hydrogen is the key ingredient in making fertilizers needed to grow food for the world. It is also used for transportation, refining oil and making steel, glass, pharmaceuticals and more. Nearly all the hydrogen today is made from hydrocarbons like coal, oil, and natural gas, which are dirty and limited resources. Water, on the other hand, is an infinite and renewable worldwide resource.

Currently, the most common method of making green hydrogen is to split water into oxygen and hydrogen with an electrolyzer using green electricity produced from solar or wind. However, green electricity is and always will be very expensive. It currently accounts for 73% of the cost of green hydrogen. By using heat directly, we can skip the expensive process of making electricity, and fundamentally lower the cost of green hydrogen. Inexpensive heat can be obtained from concentrated solar, geothermal, nuclear reactors and industrial waste heat for use in our novel low-cost thermochemical water splitting process. Working with a world class research team at UC Santa Barbara, our goal is to help usher in the green hydrogen economy that Goldman Sachs estimated to have a future market value of $12 trillion.

Safe Harbor Statement

Matters discussed in this press release contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. When used in this press release, the words “anticipate,” “believe,” “estimate,” “may,” “intend,” “expect” and similar expressions identify such forward-looking statements. Actual results, performance or achievements could differ materially from those contemplated, expressed or implied by the forward-looking statements contained herein. These forward-looking statements are based largely on the expectations of the Company and are subject to a number of risks and uncertainties. These include, but are not limited to, risks and uncertainties associated with: the impact of economic, competitive and other factors affecting the Company and its operations, markets, the impact on the national and local economies resulting from terrorist actions, the impact of public health epidemics on the global economy and other factors detailed in reports filed by the Company with the United States Securities and Exchange Commission.

Any forward-looking statement made by us in this press release is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.

Investor Relations Contact:

NewHydrogen, Inc.
ir@newhydrogen.com